China Pharmaceuticals and Healthcare Report - Q4 2014

Business Monitor International
September 10, 2014
197 Pages - SKU: BMI5325553
Countries covered: China

China Pharmaceuticals and Healthcare Report - Q4 2014

BMI View: A more 'rational' use of pharmaceuticals through pharmacoeconomics, and a crackdown onillegal rebates and corruption in China's pharmaceutical market could hinder the sector's growth potential.

However, over the long term, the government is likely to improve its investment in healthcare in order toretain public support.

Headline Expenditure Projections

Pharmaceuticals: CNY532.4bn (US$86.6bn) in 2013 to CNY616.1bn (US$99.3bn) in 2014; +15.7% inlocal currency and +14.7% in US dollar terms. Forecast broadly unchanged from Q313.

Healthcare: CNY3,230.8bn (US$525.4bn) in 2013 to CNY3,692.0bn (US$595.2bn) in 2014; +14.3% inlocal currency terms and +13.3% in US dollar terms. Forecast remains unchanged from Q313.



More Prescription Drugs reports by Business Monitor International

Venezuela Pharmaceuticals and Healthcare Report Q4 2014 by Business Monitor International
Venezuela Pharmaceuticals and Healthcare Report Q4 2014BMI View: Venezuela's improving foreign currency supply, increasing pharmaceutical imports frompolitical allies and the potential expansion of free medicine ...
United Kingdom Pharmaceuticals and Healthcare Report Q4 2014 by Business Monitor International
United Kingdom Pharmaceuticals and Healthcare Report Q4 2014BMI View: The decline in NHS pharmaceutical expenditure in 2013, despite an increase in prescriptionnumbers, does not come ...
Switzerland Pharmaceuticals and Healthcare Report Q4 2014 by Business Monitor International
Switzerland Pharmaceuticals and Healthcare Report Q4 2014BMI View: Most of Switzerland's demographic and economic indicators are favourable towards increasedpharmaceutical and healthcare spending. The proportion of ...
Qatar Pharmaceuticals and Healthcare Report Q4 2014 by Business Monitor International
Qatar Pharmaceuticals and Healthcare Report Q4 2014BMI View: The reduction of a large number of medicine prices in Qatar is likely to be detrimental topharmaceutical ...
See all reports like this >>

More China Prescription Drugs reports

China Pharmaceutical Mfg. Industry Data Report by Beijing Zeefer Consulting Ltd.
China Pharmaceutical Mfg. Industry Data ReportThis data report provides key statistics and concise analysis on pharmaceutical mfg. industry in China. It presents an overview on ...
Databook Q1 2014: China Social Media Advertising Spend - Pharmaceutical & Healthcare Industry by Socintel360
Databook Q1 2014: China Social Media Advertising Spend in Pharmaceutical & Healthcare IndustrySocial media advertising spend by pharmaceutical & healthcare brands in China stood at ...
Databook Q1 2014: China Digital Advertising Spend - Pharmaceutical & Healthcare Industry by Socintel360
Databook Q1 2014: China Digital Advertising Spend in Pharmaceutical & Healthcare IndustryOnline advertising spend by pharmaceutical & healthcare brands in China stood at US$511 million ...
Chemical Pharmaceutical: China Chemical Pharmaceutical Industry Report, 2013-2016 by Research in China
Chemical Pharmaceutical: China Chemical Pharmaceutical Industry Report, 2013-2016 Chemical pharmaceutical consists mainly of chemical drug preparation and active pharmaceutical ingredient (API), and the gross margin ...
See all reports like this >>

 

SELECT A LICENSE

    Report with 3 quarterly updates  USD 1,295  
    Report with 3 quarterly updates
3 User License
  USD 1,945  
    Report with 3 quarterly updates
5 User License
  USD 2,500  
    Report with 3 quarterly updates
Departmental/Site License
  USD 2,995  
    Global Site License Fulfilled by Publisher  USD 6,995  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!